The microtubule nexus linking amyloid beta and tau: A simple and unifying theory for the underlying cause of Alzheimer's disease. [PDF]
Shoff TA +3 more
europepmc +1 more source
Abstract Large clinical data underscore that heart failure is independently associated to an increased risk of negative cognitive outcome and dementia. Emerging evidence suggests that cerebral hypoperfusion, stemming from reduced cardiac output and vascular pathology, may contribute to the largely overlapping vascular dementia and Alzheimer's disease ...
Mauro Massussi +6 more
wiley +1 more source
The 2024 NIA-AA biological definition of Alzheimer's disease: linking biomarkers to clinical practice. [PDF]
Kobayashi G +4 more
europepmc +1 more source
Abstract Aims Amyloid cardiomyopathy is caused by the deposition of light chain (AL) or transthyretin amyloid (ATTR) fibrils, that leads to a restrictive cardiomyopathy, often resulting in heart failure (HF) with preserved or reduced ejection fraction.
Robin Willixhofer +25 more
wiley +1 more source
Real-world diagnostic performance of blood-based biomarkers for Alzheimer's disease: robust performance except after stroke and high charlson comorbidity index. [PDF]
Vigneswaran S +12 more
europepmc +1 more source
Predicting Brain Amyloid PET Positivity Using the Amyloid Beta Composite (ABC) Index in Patients With Cognitive Impairment. [PDF]
Lee J, Jung S, Lee AY.
europepmc +1 more source
CSF microtubule-associated protein 1 light chain 3A and 3B levels are associated with tau pathology and Alzheimer's disease risk through amyloid deposition and microglial signaling. [PDF]
Guo HH +16 more
europepmc +1 more source
Integration over reduction: multimodal PET and fluid biomarkers in Alzheimer's disease and beyond. [PDF]
Bluma M, Chiotis K, Nordberg A.
europepmc +1 more source
Ventricular enlargement is associated with early Alzheimer's disease pathophysiology. [PDF]
Hosseini SA +41 more
europepmc +1 more source

